Long-term outcome of placental-site trophoblastic tumours.
Kohorn
Ernest I
EI
Department of Gynecology, Yale University School of Medicine, New Haven, CT 06510, USA. ernest.kohorn@yale.edu
D000970:Antineoplastic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D006801:Humans; D011247:Pregnancy; D011379:Prognosis; D012189:Retrospective Studies; D016896:Treatment Outcome; D018245:Trophoblastic Tumor, Placental Site / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D006113:United Kingdom / Q000453:epidemiology; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology
D000970:Antineoplastic Agents; D015415:Biomarkers; D006063:Chorionic Gonadotropin